Enjoy complimentary customisation on priority with our Enterprise License!
The gout therapeutics market is projected to grow by USD 2.69 billion with a CAGR of 14%, during the forecast period 2020 to 2025.
The market research report provides valuable insights into the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentation by drug class (NSAIDs, urate-lowering agents, corticosteroids, and colchicine) and geography (North America, Europe, Asia, and ROW).
The gout therapeutics market report also offers information on several market vendors, including AstraZeneca Plc, Avion Pharmaceuticals LLC, Cadila Healthcare Ltd., Hikma Pharmaceuticals Plc, Horizon Therapeutics Plc, Ironwood Pharmaceuticals Inc., JW Pharmaceutical Corp., Selecta Biosciences Inc., Takeda Pharmaceutical Co. Ltd., and Teijin Ltd. among others.
Cadila Healthcare Ltd. - The company offers gout therapeutics products such as US RLD is used to treat and prevent low levels of blood clotting factors. The pharmaceuticals segment represents the business of integrated pharmaceutical operations with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products.
Get the Gout Therapeutics Market Size Forecast by Download Report Sample
Technavio categorizes the global gout therapeutics Market 2021-2025 market as a part of the global pharmaceuticals market within the overall healthcare industry. Our research report extensively covers external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the gout therapeutics market during the forecast period.
Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Key Gout Therapeutics Market Driver
Key Gout Therapeutics Market Challenge
This gout therapeutics market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.
Our In-house experts produce extensive information on the value chain and parent market of the gout therapeutics market, which vendors can leverage to gain a competitive advantage during the forecast period. The Value Chain information provides an end-to-end understanding of product insight and profit and also optimization and evaluation of business strategies. The players across the value chain include selective data and analysis from entire research findings as per the scope of the report.
Get a glance at the market share of various regions Requesting a PDF Sample now!
43% of the market’s growth will originate from North America during the forecast period. The US is the key market for gout therapeutics in North America. Market growth in this region will be slower than the growth of the market in other regions. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
To gain insights on the market contribution of various segments Request a PDF Sample
The gout therapeutics market share growth by the NSAIDs segment will be significant during the forecast period. Non-opioid analgesics are commonly used medications because of their efficacy in antipyretic, analgesic, and anti-inflammatory actions. The inhibition of the cyclooxygenase enzyme due to the blocking of the formation of prostaglandins in the peripheral tissues by NSAIDs will reduce the pain at the site of injury. NSAIDs are further classified into COX-1 and COX-2 inhibitors. The adverse effects associated with NSAIDs are platelet dysfunction, bleeding, increased thrombotic events, delayed bone healing, bronchospasm, and renal toxicity.
This report provides an accurate prediction of the contribution of all the segments to the growth of the gout therapeutics market size and actionable market insights on the post-COVID-19 impact on each segment.
Gout Therapeutics Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2020 |
Forecast period |
2021-2025 |
Growth momentum & CAGR |
Accelerate at a CAGR of 14% |
Market growth 2021-2025 |
$ 2.69 billion |
Market structure |
Fragmented |
YoY growth (%) |
13.81 |
Regional analysis |
North America, Europe, Asia, and ROW |
Performing market contribution |
North America at 43% |
Key countries |
US, UK, Germany, Japan, and China |
Competitive landscape |
Leading companies, Competitive Strategies, Consumer engagement scope |
Key companies profiled |
AstraZeneca Plc, Avion Pharmaceuticals LLC, Cadila Healthcare Ltd., Hikma Pharmaceuticals Plc, Horizon Therapeutics Plc, Ironwood Pharmaceuticals Inc., JW Pharmaceutical Corp., Selecta Biosciences Inc., Takeda Pharmaceutical Co. Ltd., and Teijin Ltd. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.